| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.02 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |